292 related articles for article (PubMed ID: 26417670)
1. Oxidative stress promotes benign prostatic hyperplasia.
Vital P; Castro P; Ittmann M
Prostate; 2016 Jan; 76(1):58-67. PubMed ID: 26417670
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-8 is a paracrine inducer of fibroblast growth factor 2, a stromal and epithelial growth factor in benign prostatic hyperplasia.
Giri D; Ittmann M
Am J Pathol; 2001 Jul; 159(1):139-47. PubMed ID: 11438462
[TBL] [Abstract][Full Text] [Related]
3. Sex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartment.
Nicholson TM; Sehgal PD; Drew SA; Huang W; Ricke WA
Differentiation; 2013; 85(4-5):140-9. PubMed ID: 23792768
[TBL] [Abstract][Full Text] [Related]
4. Targeting benign prostate hyperplasia treatments: AR/TGF-β/NOX4 inhibition by apocynin suppresses inflammation and proliferation.
Jin BR; Kim HJ; Na JH; Lee WK; An HJ
J Adv Res; 2024 Mar; 57():135-147. PubMed ID: 37061215
[TBL] [Abstract][Full Text] [Related]
5. Promotion of epithelial hyperplasia by interleukin-8-CXCR axis in human prostate.
Smith DK; Hasanali SL; Wang J; Kallifatidis G; Morera DS; Jordan AR; Terris MK; Klaassen Z; Bollag R; Lokeshwar VB; Lokeshwar BL
Prostate; 2020 Sep; 80(12):938-949. PubMed ID: 32542667
[TBL] [Abstract][Full Text] [Related]
6. Periodontitis Exacerbates Benign Prostatic Hyperplasia through Regulation of Oxidative Stress and Inflammation.
Fang C; Wu L; Zhao MJ; Deng T; Gu JM; Guo XP; Li C; Li W; Zeng XT
Oxid Med Cell Longev; 2021; 2021():2094665. PubMed ID: 34707774
[TBL] [Abstract][Full Text] [Related]
7. The senescence-associated secretory phenotype promotes benign prostatic hyperplasia.
Vital P; Castro P; Tsang S; Ittmann M
Am J Pathol; 2014 Mar; 184(3):721-31. PubMed ID: 24434012
[TBL] [Abstract][Full Text] [Related]
8. Elevated expression of HIF-lα in actively growing prostate tissues is associated with clinical features of benign prostatic hyperplasia.
Wu F; Ding S; Li X; Wang H; Liu S; Wu H; Bi D; Ding K; Lu J
Oncotarget; 2016 Mar; 7(11):12053-62. PubMed ID: 26919249
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-18 may lead to benign prostatic hyperplasia via thrombospondin-1 production in prostatic smooth muscle cells.
Hamakawa T; Sasaki S; Shibata Y; Imura M; Kubota Y; Kojima Y; Kohri K
Prostate; 2014 May; 74(6):590-601. PubMed ID: 24615654
[TBL] [Abstract][Full Text] [Related]
10. Relationship between the prostatic tissue components and natural history of benign prostatic hyperplasia.
Matsuda T; Fujime M; Suda K
Anal Quant Cytol Histol; 2006 Jun; 28(3):121-4. PubMed ID: 16786720
[TBL] [Abstract][Full Text] [Related]
11. Elevated epithelial expression of interleukin-8 correlates with myofibroblast reactive stroma in benign prostatic hyperplasia.
Schauer IG; Ressler SJ; Tuxhorn JA; Dang TD; Rowley DR
Urology; 2008 Jul; 72(1):205-13. PubMed ID: 18314176
[TBL] [Abstract][Full Text] [Related]
12. Potential role of oxidative stress in pathogenesis of benign prostatic hyperplasia in male dogs.
Domosławska-Wyderska A; Zduńczyk S; Rafalska A
Reprod Domest Anim; 2024 May; 59(5):e14580. PubMed ID: 38698701
[TBL] [Abstract][Full Text] [Related]
13. The relative proportion of stromal and epithelial hyperplasia is related to the development of symptomatic benign prostate hyperplasia.
Shapiro E; Becich MJ; Hartanto V; Lepor H
J Urol; 1992 May; 147(5):1293-7. PubMed ID: 1373778
[TBL] [Abstract][Full Text] [Related]
14. Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food intervention.
Chen L; Stacewicz-Sapuntzakis M; Duncan C; Sharifi R; Ghosh L; van Breemen R; Ashton D; Bowen PE
J Natl Cancer Inst; 2001 Dec; 93(24):1872-9. PubMed ID: 11752012
[TBL] [Abstract][Full Text] [Related]
15.
Elsherbini DMA; Almohaimeed HM; El-Sherbiny M; Mohammedsaleh ZM; Elsherbiny NM; Gabr SA; Ebrahim HA
Antioxidants (Basel); 2022 Jun; 11(6):. PubMed ID: 35740046
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of serum protein-bound sialic acid in benign and malignant prostatic growth: possible role of oxidative stress in sialic acid homeostasis.
Goswami K; Nandeesha H; Koner BC; Nandakumar DN
Prostate Cancer Prostatic Dis; 2007; 10(4):356-9. PubMed ID: 17404581
[TBL] [Abstract][Full Text] [Related]
17. Protease-activated receptor-1 upregulates fibroblast growth factor 7 in stroma of benign prostatic hyperplasia.
Wang W; Zhang X; Mize GJ; Takayama TK
Prostate; 2008 Jul; 68(10):1064-75. PubMed ID: 18386288
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor axis abnormalities in prostatic stromal cells from patients with benign prostatic hyperplasia.
Cohen P; Peehl DM; Baker B; Liu F; Hintz RL; Rosenfeld RG
J Clin Endocrinol Metab; 1994 Nov; 79(5):1410-5. PubMed ID: 7525636
[TBL] [Abstract][Full Text] [Related]
19. Distinctive gene expression of prostatic stromal cells cultured from diseased versus normal tissues.
Zhao H; Ramos CF; Brooks JD; Peehl DM
J Cell Physiol; 2007 Jan; 210(1):111-21. PubMed ID: 17044071
[TBL] [Abstract][Full Text] [Related]
20. Cellular senescence in the pathogenesis of benign prostatic hyperplasia.
Castro P; Giri D; Lamb D; Ittmann M
Prostate; 2003 Apr; 55(1):30-8. PubMed ID: 12640658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
